At a glance
ClinicalIndex Comparison RecordN/ACompleted· 339 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding
Shanghai Jiao Tong University School of Medicine·observational·Posted Apr 1, 2013·Updated Jan 25, 2017
In Brief
An observational study for Gastrointestinal Bleeding. Completed, enrolled 339 participants.
Detailed Summary
The investigators investigated the rebleeding rate the risk factors for rebleeding after long-term follow-up (≥12 months) in patients who underwent capsule endoscopy for obscure gastrointestinal bleeding.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Bleeding
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2002
Primary CompletionJan 2013
First PostedApr 2013
TodayJul 2026
First PostedApr 1, 2013
Enrollment StartJun 1, 2002
Primary CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10.6 yearsPosted 13.3 years ago